Michael Polansky, Lady Gaga’s fiancé, has launched a biotech startup called Outer Biosciences, which uses technology to work with human skin samples that are typically discarded after surgery. According to the reports, the company’s approach involves sourcing leftover skin tissue and applying AI to help guide research tied to skin products and disease-related treatments.
Both outlets describe Outer Biosciences as an AI- and skin-based project, but they differ in emphasis. Billboard focuses on the company’s use of AI to predict the next generation of skin-disease treatments and highlights the role of discarded surgical skin in the research pipeline. The other article frames the story more around the “weird” aspect of harvesting skin and characterizes the effort as also aiming at advanced cosmetic product development, while noting that Polansky has discussed the startup publicly in an interview.
Across the coverage, the common elements are Polansky’s launch of Outer Biosciences, its use of AI, and its reliance on discarded human skin obtained from plastic surgery contexts for research.
